Ignite Creation Date:
2024-05-06 @ 1:39 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04087200
Status:
RECRUITING
Last Update Posted:
2019-09-12
First Post:
2019-08-30
Brief Title:
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
Sponsor:
Centro Cardiopatici Toscani
Organization:
Centro Cardiopatici Toscani
Study Overview
Official Title:
The Protective Effect of Early High Dose High-intensity Statins on Cardiovascular and Renal Events in Patients With Acute Coronary Syndrome
Status:
RECRUITING
Status Verified Date:
2019-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRATO-ACS
Brief Summary:
Registration of all ACS patients STEMI and NSTEMI admitted to the cardiology ward and scheduled for early invasive strategy The aim is to evaluate the protective effects of early on admission high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients
Detailed Description:
Statin-naive patients and those on statin therapy with ACS who are admitted to the cardiology ward of our public National Health Service hospital and are scheduled for early invasive strategy receive immediately on admission always before angiographic procedure high-dose statin therapy Either atorvastatin 80 mg or rosuvastatin 40 mg is administered at the discretion of the physician During hospitalization various pertinent cardiac and renal parameters including hematological angiographic clinical data are registered in a dedicated database Clinical follow-up and hematological analysis are done 1 month after discharge A second follow-up either clinical or by telephone is done 1 year after discharge
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None